MARKET

PGABF

PGABF

Prostatype Genomics AB
OTCMQB
0.400
NaN%
Closed 09:30 12/04 EST
OPEN
--
PREV CLOSE
0.400
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.400
52 WEEK LOW
0.400
MARKET CAP
14.80M
P/E (TTM)
-2.2701
1D
5D
1M
3M
1Y
5Y
1D
No Data
About PGABF
Prostatype Genomics AB is a Sweden-based company developing gene tests. The Company's business model and concept is to manufacture, market and sell the Prostatype Test System as one prognostic package consisting of the Prostatype RTqPCR kit, the patient database and the evaluation software and accessories P-score. The test is supposed to check the aggressiveness of the prostate cancer in order to help clinicians and patients to make correct treatment decisions. Prostatype analyzes the gene expression in cancer cells extracted from prostate tissue and gives, in combination with an advanced algorithm and data analysis, decision support for optimal treatment of individual patients once prostate cancer has been confirmed.

Webull offers Prostatype Genomics AB stock information, including OTCMQB: PGABF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PGABF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PGABF stock methods without spending real money on the virtual paper trading platform.